Angiodynamics Stock Gross Profit
| ANGO Stock | USD 6.99 0.16 2.34% |
AngioDynamics fundamentals help investors to digest information that contributes to AngioDynamics' financial success or failures. It also enables traders to predict the movement of AngioDynamics Stock. The fundamental analysis module provides a way to measure AngioDynamics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AngioDynamics stock.
AngioDynamics |
AngioDynamics Company Gross Profit Analysis
AngioDynamics' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current AngioDynamics Gross Profit | 174.25 M |
Most of AngioDynamics' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AngioDynamics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, AngioDynamics reported 174.25 M of gross profit. This is 92.23% lower than that of the Health Care Equipment & Supplies sector and 81.11% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.36% higher than that of the company.
AngioDynamics Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AngioDynamics' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AngioDynamics could also be used in its relative valuation, which is a method of valuing AngioDynamics by comparing valuation metrics of similar companies.AngioDynamics is currently under evaluation in gross profit category among its peers.
AngioDynamics Fundamentals
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.0612 | ||||
| Profit Margin | (0.83) % | ||||
| Operating Margin | (0.13) % | ||||
| Current Valuation | 233.83 M | ||||
| Shares Outstanding | 40.63 M | ||||
| Shares Owned By Insiders | 5.47 % | ||||
| Shares Owned By Institutions | 81.33 % | ||||
| Number Of Shares Shorted | 1.23 M | ||||
| Price To Earning | 7.90 X | ||||
| Price To Book | 1.44 X | ||||
| Price To Sales | 0.97 X | ||||
| Revenue | 303.91 M | ||||
| Gross Profit | 174.25 M | ||||
| EBITDA | (14.29 M) | ||||
| Net Income | (184.35 M) | ||||
| Cash And Equivalents | 24.56 M | ||||
| Cash Per Share | 0.31 X | ||||
| Total Debt | 5.91 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 2.28 X | ||||
| Book Value Per Share | 4.79 X | ||||
| Cash Flow From Operations | (28.16 M) | ||||
| Short Ratio | 1.67 X | ||||
| Earnings Per Share | (6.05) X | ||||
| Price To Earnings To Growth | 1.87 X | ||||
| Target Price | 13.0 | ||||
| Number Of Employees | 748 | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 284.03 M | ||||
| Total Asset | 317.67 M | ||||
| Retained Earnings | (395.2 M) | ||||
| Working Capital | 102.1 M | ||||
| Current Asset | 146.25 M | ||||
| Current Liabilities | 66.73 M | ||||
| Net Asset | 317.67 M |
About AngioDynamics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AngioDynamics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AngioDynamics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AngioDynamics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with AngioDynamics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.Moving against AngioDynamics Stock
| 0.56 | VMD | Viemed Healthcare | PairCorr |
| 0.5 | CVS | CVS Health Corp Aggressive Push | PairCorr |
| 0.45 | MBOT | Microbot Medical | PairCorr |
| 0.4 | WGS | GeneDx Holdings Corp | PairCorr |
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out AngioDynamics Piotroski F Score and AngioDynamics Altman Z Score analysis. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.